SCHEMBL6408893

SCHEMBL6408893

COc1ccc(COCC2C(C(=O)OC(C)(C)C)C2(C)C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.41
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
HDAC4 P56524 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HTT P42858 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CACNA1B Q00975 2/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MEN1 O00255 1/20 0.36
EPHX2 P34913 1/20 0.36
KMT2A Q03164 1/20 0.36
NR1H4 Q96RI1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407683 0.87 MMP1 (0.44) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL6406120 0.86 L3MBTL1 (0.41) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL6406124 0.84 PPARA (0.41) L3MBTL1
SCHEMBL6408318 0.84 ALDH1A1 (0.42) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6406010 0.83 MMP1 (0.45) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL6409443 0.83 S1PR1 (0.41) POLBCA2MEN1KMT2AALDH1A1
SCHEMBL6407457 0.81 ALDH1A1 (0.37) L3MBTL1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL6408847 0.80 FFAR1 (0.35) L3MBTL1MMP1MMP2MMP3MMP9
SCHEMBL6406894 0.80 CACNA1B (0.43) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6407225 0.80 MMP1 (0.37) L3MBTL1MMP1MMP2MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 L3MBTL1 2735/4885MMP1 3579/4885MMP2 2857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.